Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3γ1(Ala-Ala) in the treatment of acute renal allograft rejection

Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3γ1(Ala-Ala) in the treatment of acute renal allograft rejection

Saved in:
Bibliographic Details
Published in:Transplantation Vol. 68; no. 5; pp. 608 - 616
Main Authors: WOODLE, E. S, DANLIN XU, THISTLETHWAITE, J. R, ZIVIN, R. A, AUGER, J, CHARETTE, J, O'LAUGHLIN, R, PEACE, D, JOLLIFFE, L. K, HAVERTY, T, BLUESTONE, J. A
Format: Journal Article
Language:English
Published: Hagerstown, MD Lippincott 15-09-1999
Subjects:
Biological and medical sciences
Immunomodulators
Medical sciences
Pharmacology. Drug treatments
Kidney disease
Human
Urinary system disease
Acute
Transplantation
Homotransplantation
Kidney
Immunomodulator
Rejection
Chemotherapy
Treatment
Immunotherapy
Phase I trial
Complication
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0041-1337
1534-6080
DOI:10.1097/00007890-199909150-00003